Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Cabaletta Bio, Inc. (CABA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Lynx1 Capital Management LP reports a 9.7% stake in Cabaletta Bio, Inc. |
| 02/14/2023 |
SC 13G/A
| Cormorant Asset Management, LP reports a 6.8% stake in Cabaletta Bio, Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2023 |
SC 13G/A
| Nichtberger Steven reports a 7.7% stake in Cabaletta Bio, Inc. |
| 02/09/2023 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 10% stake in Cabaletta Bio, Inc. |
| 02/14/2022 |
SC 13G/A
| Redmile Group, LLC reports a 2.5% stake in Cabaletta BIO, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Cormorant Asset Management, LP reports a 4.1% stake in Cabaletta Bio, Inc. |
| 02/14/2022 |
SC 13G/A
| CITADEL ADVISORS LLC reports a 5.4% stake in Cabaletta Bio, Inc. |
| 02/10/2022 |
SC 13G/A
| ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 8.6% stake in Cabaletta Bio, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Boxer Capital, LLC reports a 8.9% stake in Cabaletta Bio, Inc. |
| 02/14/2020 |
SC 13G/A
| Cormorant Asset Management, LLC reports a 8.8% stake in Cabaletta Bio, Inc. |
| 02/13/2020 |
SC 13G/A
| Flynn James E reports a 6.8% stake in Cabaletta Bio, Inc. |
|
|